Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety and effectiveness of Pyridoxal 5'-Phosphate on
the reduction of expressed symptoms of tardive dyskinesia in patients with schizophrenia and
schizoaffective disorders.
Phase:
Phase 2
Details
Lead Sponsor:
Medicure
Treatments:
Pyridoxal Pyridoxal Phosphate Pyridoxine Vitamin B 6